These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16963622)
41. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus. Mathieu C Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394 [TBL] [Abstract][Full Text] [Related]
42. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
43. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial. Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W; Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271 [TBL] [Abstract][Full Text] [Related]
44. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes. Rave K; Heise T; Pfützner A; Boss AH Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744 [No Abstract] [Full Text] [Related]
45. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032 [TBL] [Abstract][Full Text] [Related]
46. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Svendsen PF; Nilas L; Madsbad S; Holst JJ Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579 [TBL] [Abstract][Full Text] [Related]
47. [Inhaled human insulin (Exubera): a revolution?]. Daubresse JC; Sternon J Rev Med Brux; 2006; 27(6):493-7. PubMed ID: 17256415 [TBL] [Abstract][Full Text] [Related]
48. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Steil GM; Rebrin K; Mittelman SD; Bergman RN Diabetes; 1998 May; 47(5):714-20. PubMed ID: 9588441 [TBL] [Abstract][Full Text] [Related]
49. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M; Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648 [TBL] [Abstract][Full Text] [Related]
50. Effect of exogenous intermittent recombinant human PTH 1-34 administration and chronic endogenous parathyroid hormone excess on glucose homeostasis and insulin sensitivity. Anastasilakis AD; Efstathiadou Z; Plevraki E; Koukoulis GN; Slavakis A; Kita M; Avramidis A Horm Metab Res; 2008 Oct; 40(10):702-7. PubMed ID: 18553257 [TBL] [Abstract][Full Text] [Related]
51. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials. Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080 [No Abstract] [Full Text] [Related]
52. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
53. Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection. Cherrington AD; Neal DW; Edgerton DS; Glass D; Bowen L; Hobbs CH; Leach C; Rosskamp R; Strack TR Diabetes; 2004 Apr; 53(4):877-81. PubMed ID: 15047601 [TBL] [Abstract][Full Text] [Related]
55. The clinical pharmacology of human insulin (Novo) in normal subjects. Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG Diabetes Care; 1983; 6 Suppl 1():13-6. PubMed ID: 6133710 [TBL] [Abstract][Full Text] [Related]
57. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats. Yang DB; Zhu JB; Zhu H; Zhang XS Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667 [TBL] [Abstract][Full Text] [Related]